| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 85700 | Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) | 0.0361455178924431 | 0.43096917 |
| NSC 112152 | 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) | 0.0376362543535811 | 0.55893711 |
| NSC 123978 | Sarveroside | 0.0376362543535811 | 0.33559341 |
| NSC 134754 | Null | 0.0376362543535811 | 0.47127551 |
| NSC 145168 | 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- | 0.0376362543535811 | 0.67562766 |
| NSC 243022 | Cinerubin A hydrochloride | 0.0376362543535811 | 0.38038444 |
| NSC 31709 | Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride | 0.0376362543535811 | 0.35142852 |
| NSC 327182 | L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- | 0.0376362543535811 | 0.20064185 |
| NSC 340847 | 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- | 0.0376362543535811 | 0.35349215 |
| NSC 376248 | Nordracorubin | 0.0376362543535811 | 0.36097746 |